The University of Southampton
University of Southampton Institutional Repository

Transcatheter aortic valve implantation: the state of play

Transcatheter aortic valve implantation: the state of play
Transcatheter aortic valve implantation: the state of play
Aortic stenosis is the most commonly acquired valvular heart disease in the Western world. Surgical aortic valve replacement is currently the gold-standard treatment for patients with severe symptomatic aortic stenosis. Without surgery, the prognosis is extremely poor, with a 3-year survival rate of less than 30%. Transcatheter aortic valve implantation (TAVI) is a rapidly evolving novel technique that was first introduced in 2002 and is currently available in Europe as an alternative to conventional aortic valve replacement for patients with severe symptomatic aortic stenosis who are deemed to be at too high a risk for open heart surgery. This article describes the TAVI technique and patient selection criteria. We explore how far we have come with advances in TAVI and analyze the short- and medium-term outcome data reported on TAVI so far. We will also look at the potential future role of TAVI and the challenges involved in setting up a TAVI service
1479-6678
243-254
Sambu, Nalyaka
7d0ba3fb-e39e-48d7-a0e4-ce249acc5980
Curzen, N.
70f3ea49-51b1-418f-8e56-8210aef1abf4
Sambu, Nalyaka
7d0ba3fb-e39e-48d7-a0e4-ce249acc5980
Curzen, N.
70f3ea49-51b1-418f-8e56-8210aef1abf4

Sambu, Nalyaka and Curzen, N. (2010) Transcatheter aortic valve implantation: the state of play. Future Cardiology, 6 (2), 243-254. (doi:10.2217/fca.10.3). (PMID:20230265)

Record type: Article

Abstract

Aortic stenosis is the most commonly acquired valvular heart disease in the Western world. Surgical aortic valve replacement is currently the gold-standard treatment for patients with severe symptomatic aortic stenosis. Without surgery, the prognosis is extremely poor, with a 3-year survival rate of less than 30%. Transcatheter aortic valve implantation (TAVI) is a rapidly evolving novel technique that was first introduced in 2002 and is currently available in Europe as an alternative to conventional aortic valve replacement for patients with severe symptomatic aortic stenosis who are deemed to be at too high a risk for open heart surgery. This article describes the TAVI technique and patient selection criteria. We explore how far we have come with advances in TAVI and analyze the short- and medium-term outcome data reported on TAVI so far. We will also look at the potential future role of TAVI and the challenges involved in setting up a TAVI service

This record has no associated files available for download.

More information

Published date: March 2010
Organisations: Human Development & Health

Identifiers

Local EPrints ID: 355244
URI: http://eprints.soton.ac.uk/id/eprint/355244
ISSN: 1479-6678
PURE UUID: 4f762f96-47bb-4491-82e8-6cc64f4342cf
ORCID for N. Curzen: ORCID iD orcid.org/0000-0001-9651-7829

Catalogue record

Date deposited: 19 Aug 2013 12:06
Last modified: 15 Mar 2024 03:23

Export record

Altmetrics

Contributors

Author: Nalyaka Sambu
Author: N. Curzen ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×